What is the appropriate next step for a patient with epigastric pain, nausea, vomiting, recent discontinuation of prednisone, currently taking sucralfate and pantoprazole, who now has markedly elevated AST and ALT, elevated alkaline phosphatase, and hyperbilirubinemia after being told the labs are normal and who is refusing further telephone contact?

Critical Medical and Medicolegal Emergency Requiring Immediate Action

This patient has severe acute hepatocellular injury (AST 501, ALT 667) with cholestasis (ALP 261, bilirubin 3.0) that was incorrectly dismissed as "normal" by another provider, and you must immediately document this dangerous situation, attempt emergency contact through alternative means, and potentially involve adult protective services given the patient's refusal of life-saving communication. 1

Severity Classification and Urgency

This patient has moderate-to-severe hepatocellular injury based on aminotransferase elevations 15-20 times the upper limit of normal (assuming ULN ~30-33 IU/L for ALT), combined with significant hyperbilirubinemia (bilirubin 3.0 mg/dL) and elevated alkaline phosphatase indicating a mixed hepatocellular-cholestatic pattern 1. This represents a medical emergency requiring urgent evaluation, as elevated bilirubin with alkaline phosphatase at onset predicts prolonged recovery and worse outcomes in drug-induced liver injury 2.

Immediate Clinical Concerns:

• Drug-induced liver injury (DILI) is the most likely diagnosis given recent prednisone exposure (known rare hepatotoxin) 3 and current pantoprazole use (rare but documented hepatotoxin) 4
• Acute liver failure risk: Bilirubin >3.0 mg/dL with coagulopathy (INR) and encephalopathy would meet criteria for acute liver failure
• Hy's Law concern: The combination of aminotransferases >3x ULN with bilirubin >2x ULN (without elevated ALP predominance) carries 10% mortality risk if not addressed 1

Immediate Actions Required (Next 24-48 Hours)

1. Emergency Documentation and Communication Attempts

Document everything immediately in the medical record including:

• The exact laboratory values and their severity classification 1
• Your attempts to contact the patient and her refusal
• The other provider's incorrect statement that "labs look normal"
• Your clinical assessment of the urgent medical situation
• All subsequent attempts at contact

Attempt alternative contact methods 1:

• Send certified letter to patient's address documenting the critical laboratory abnormalities and need for immediate evaluation
• Contact emergency contact persons listed in her chart
• If available, contact family members who may facilitate communication
• Consider having a different staff member attempt contact, as the patient may respond differently

2. Immediate Laboratory and Clinical Assessment Needed

The patient requires urgent additional testing within 24-48 hours 1:

• Hepatic synthetic function: INR/PT, albumin (you noted albumin is normal, which is reassuring)
• Complete hepatitis panel: Hepatitis A IgM, Hepatitis B surface antigen and core antibody, Hepatitis C antibody
• Autoimmune markers: ANA, anti-smooth muscle antibody, immunoglobulins (to exclude autoimmune hepatitis, which can be triggered by drug exposure)
• Additional liver chemistries: GGT to better characterize cholestatic component
• Acetaminophen level (if any possibility of ingestion)
• Right upper quadrant ultrasound is the appropriate initial imaging for abnormal liver function tests with this pattern 1

3. Medication Management - Critical Priority

Both pantoprazole and prednisone must be discontinued immediately 5, 6, 4, 3:

• Pantoprazole hepatotoxicity is rare but well-documented, presenting as mixed hepatocellular-cholestatic injury that resolves within weeks of discontinuation 4
• Prednisone/methylprednisolone hepatotoxicity is rare but documented, causing mixed hepatocellular-cholestatic injury similar to this patient's pattern 3
• The patient has already discontinued prednisone, but pantoprazole continuation is dangerous 4
• Sucralfate alone can be continued for gastric protection if needed, as it has minimal systemic absorption and no hepatotoxicity 7

4. Medicolegal and Ethical Considerations

This situation has significant medicolegal implications:

• Another provider gave dangerously incorrect information ("labs look normal") that could result in patient harm or death
• The patient's refusal of contact does not absolve you of responsibility to attempt reasonable notification
• Consider involving your risk management/legal department for guidance on:
  • Mandatory reporting requirements in your jurisdiction
  • Whether adult protective services should be contacted given potential self-harm through medical refusal
  • Documentation requirements for patient refusal of care

If the patient has capacity and continues to refuse contact after documented attempts, you have fulfilled your duty, but this must be thoroughly documented 1.

Clinical Reasoning and Differential Diagnosis

Most Likely Diagnosis: Drug-Induced Liver Injury (DILI)

The temporal relationship strongly suggests DILI 2, 4, 3:

• Recent prednisone exposure (discontinued 2 weeks ago)
• Ongoing pantoprazole exposure
• Mixed hepatocellular-cholestatic pattern typical of both drugs
• No mention of alcohol use or other risk factors

Prognosis factors for DILI recovery 2:

• Higher bilirubin at onset (this patient has 3.0 mg/dL) predicts longer recovery
• Higher ALP at onset (this patient has 261 U/L) predicts longer recovery
• This patient is at high risk for prolonged recovery (>6 months) based on these parameters

Alternative Diagnoses to Exclude

Acute viral hepatitis 1:

• Can present identically with marked aminotransferase elevation
• Requires serologic testing to exclude

Autoimmune hepatitis 1:

• Can be triggered by drug exposure
• Requires ANA, anti-smooth muscle antibody testing
• May require liver biopsy if serologies positive

Biliary obstruction 1:

• Less likely given predominant aminotransferase elevation (not ALP predominant)
• However, ALP 261 with bilirubin 3.0 requires ultrasound to exclude 1

Ischemic hepatitis 1:

• Would typically show much higher aminotransferases (>1000-3000 IU/L)
• Associated with hypotension or cardiac event
• Less likely given clinical presentation

If Patient Agrees to Evaluation: Recommended Workup

Imaging

Ultrasound abdomen is the appropriate initial imaging 1:

• Evaluates for biliary obstruction, hepatic steatosis, masses
• Non-invasive, no radiation
• Sensitivity 84.8% and specificity 93.6% for moderate-severe steatosis 1

Gastroenterology/Hepatology Referral

Urgent GI/hepatology consultation is mandatory despite the other provider's incorrect advice 1:

• This level of liver injury requires specialist evaluation
• May need liver biopsy if etiology unclear or recovery delayed
• Specialist can guide monitoring and determine if corticosteroids indicated (paradoxically, steroids may help autoimmune hepatitis but caused this injury if prednisone-induced)

Critical Pitfalls to Avoid

1. Do not assume the patient understands the severity - the other provider told her labs were "normal," creating false reassurance
2. Do not delay action waiting for patient cooperation - document attempts and involve appropriate authorities if needed
3. Do not continue hepatotoxic medications - both pantoprazole and any resumption of prednisone are contraindicated 4, 3
4. Do not miss acute liver failure - if INR becomes elevated or patient develops confusion, this is a transplant-level emergency
5. Do not ignore the medicolegal implications - another provider's dangerous misinformation must be addressed through appropriate channels

Monitoring Plan If Patient Engages

Weekly laboratory monitoring initially 2:

• AST, ALT, ALP, total and direct bilirubin, INR
• Most DILI cases improve within 2-8 weeks after drug discontinuation 4
• This patient's high bilirubin and ALP predict recovery >6 months 2

Indications for hospitalization 1:

• INR >1.5
• Bilirubin continues rising
• Development of confusion/encephalopathy
• Inability to maintain oral intake due to nausea/vomiting